Publikationen

Ausgewählte aktuelle Publikationen von Prof. Dr. rer. nat Boris Schmidt

  • B. Schmidt, D. Meid, D. Kieser, Safe and Fast Tetrazole Formation in Ionic Liquids, Tetrahedron 2007, 63, 492-
    496. http://dx.doi.org/10.1016/j.tet.2006.10.057 (IF 2.64)
  • A. Zall, D. Bensinger, B. Schmidt, Oxidative homologation of aldehydes to α-ketoaldehydes by iodoform, IBX
    and dimethylsulfoxide. Eur. J. Org. Chem. 2012 accepted 22.12.2011. http://dx.doi.org/10.1002/ejoc.201101835
  • L. Danielyan*, A. Lourhmati, S.Verleysdonk, B. Proksch, S. Umbreen, B. Schmidt, C.H. Gleiter. Angiotensin
    receptor type 1 blockade in astrocytes decreases hypoxia-induced cytotoxicity and inflammation. Neurochemical
    Research 2007, 9, 1489-1498. http://dx.doi.org/10.1007/s11064-007-9337-6 (IF 2.14)
  • D. Werner, U. Werner, A.Meybaum; B. Schmidt, S.Umbreen, A. Grosch; H. G. Lestin; B. Graf; O.Zolk; M.F.
    Fromm. Determinants of steady-state torasemide pharmacokinetics: Impact of gender, pharmacogenetic factors
    and angiotensin II receptor blockers. Clinical Pharmacokinetics 2008, 47(5), 323-32. (IF 4.11)
  • F. Lo Monte, T. Kramer, J. Gu, U. Anumala, L. Marinelli, V. La Pietra, E. Novellino, B. Franco, D.
    Demedts, F. Van Leuven, A. Fuertes, J. Dominguez, B. Plotkin, H. Eldar-Finkelman, B. Schmidt.
    Identification of Glycogen Synthase Kinase-3 Inhibitors with a Selective Sting for Glycogen Synthase
    Kinase-3α. J. Medicinal Chemistry 2012, 55 (9), 4407–4424. DOI 10.1021/jm300309a
  • F. Lo Monte, T. Kramer, J. Gu, M. Brodrecht, J. Pilakowski, Ana Fuertes, J. M. Dominguez, B. Plotkin, H. Eldar-
    Finkelman, B. Schmidt, Structure-based optimization of oxadiazole-based GSK-3 inhibitors. European J. Med.
    Chem. 2012, accepted 3.6.2012. http://dx.doi.org/10.1016/j.ejmech.2012.06.006
  • A. Boländer, D. Kieser, C. Voss, S. Bauer, C. Schön, S. Burgold, T. Bittner, J. Hölzer, R. Heyny-von
    Haußen, G. Mall, V. Goetschy, C. Czech, H. Knust, R. Berger, J. Herms, I. Hilger, B. Schmidt.
    Bis(arylvinyl)pyrazines, -pyrimidines and -pyridazines as Imaging Agents for Tau Fibrils and β-Amyloid
    Plaques in Alzheimer’s Disease Models J. Medicinal Chemistry 2012, accepted:
  • Elucidation of α-Keto-Aldehyde Binding Mechanism Reveals a Novel Lead Structure Motif for Proteasome
    Inhibition. M. Poynor, N. Gallastegui, M. Stein, B. Schmidt, P. M. Kloetzel, R. Huber, M. Groll.
    Angew. Chemie 2011, 123 (2), 563-566. http://onlinelibrary.wiley.com/doi/10.1002/ange.201005488/abstract
  • V. Lo Sardo, C. Zuccato, G. Gaudenzi, B. Vitali, C. Ramos, M. Tartari, M.A. Myre, J.A. Walker, A. Postocchi, L.
    Conti, M. Valenza, B. Drung, B. Schmidt, J. Gusella, S. Zeitlin, F. Cotelli, E. Cattaneo. An evolutionary recent
    neuroepithelial cell adhesion function of huntingtin implicates ADAM10-Ncadherin.
    Nature Neuroscience 2012, 15, 713–721. (IF 14.19), dx.doi.org/10.1038/nn.3080
  • T. Kramer, F. Lo Monte, S. Göring, G.M. Okala Amombo, B. Schmidt. ACS Chemical Neuroscience 2012, 3(3),
    151-160, Small molecule kinase inhibitors for LRRK2 and their application to Parkinson´s disease models
    http://pubs.acs.org/doi/abs/10.1021/cn200117j
  • T. Kramer, Boris Schmidt, F. Lo Monte, International Journal of Alzheimer's Disease 2012, Small-molecule
    inhibitors of GSK-3 - Structural insights and their application to Alzheimer´s disease models, accepted 31.1.2012.
    http://www.hindawi.com/journals/ijad/aip/381029/
 

Unsere Webseiten verwenden Cookies zur Verbesserung der Bedienung und des Angebots sowie zur Auswertung von Webseitenbesuchen. Einzelheiten über die von uns eingesetzten Cookies und die Möglichkeit diese abzulehnen, finden Sie in unseren Datenschutzhinweisen.